Form 8-K - Current report:
SEC Accession No. 0001171843-25-002110
Filing Date
2025-04-09
Accepted
2025-04-09 16:21:02
Documents
13
Period of Report
2025-04-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_040825.htm   iXBRL 8-K 24382
  Complete submission text file 0001171843-25-002110.txt   197739

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crvs-20250409.xsd EX-101.SCH 3030
3 XBRL LABEL FILE crvs-20250409_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE crvs-20250409_pre.xml EX-101.PRE 22369
15 EXTRACTED XBRL INSTANCE DOCUMENT f8k_040825_htm.xml XML 3707
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 25825478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)